MX9302161A - Compuestos triciclicos antagonistas de la taquiqu inina, proceso para su preparcion y composiciones farmaceuticas que los contienen. - Google Patents

Compuestos triciclicos antagonistas de la taquiqu inina, proceso para su preparcion y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9302161A
MX9302161A MX9302161A MX9302161A MX9302161A MX 9302161 A MX9302161 A MX 9302161A MX 9302161 A MX9302161 A MX 9302161A MX 9302161 A MX9302161 A MX 9302161A MX 9302161 A MX9302161 A MX 9302161A
Authority
MX
Mexico
Prior art keywords
preparation
pharmaceutical compositions
taquiqu
inina
contain
Prior art date
Application number
MX9302161A
Other languages
English (en)
Spanish (es)
Inventor
Carlo Alberto Maggi
Laura Quartara
Vincenzo Pavone
Angelina Lombardi
Carlo Pedone
Original Assignee
Menarini Ind Farmaceutiche R S
Malesci Inst Farmacob S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ind Farmaceutiche R S, Malesci Inst Farmacob S P A filed Critical Menarini Ind Farmaceutiche R S
Publication of MX9302161A publication Critical patent/MX9302161A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9302161A 1992-04-15 1993-04-14 Compuestos triciclicos antagonistas de la taquiqu inina, proceso para su preparcion y composiciones farmaceuticas que los contienen. MX9302161A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920089A IT1262902B (it) 1992-04-15 1992-04-15 Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.

Publications (1)

Publication Number Publication Date
MX9302161A true MX9302161A (es) 1994-05-31

Family

ID=11350056

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302161A MX9302161A (es) 1992-04-15 1993-04-14 Compuestos triciclicos antagonistas de la taquiqu inina, proceso para su preparcion y composiciones farmaceuticas que los contienen.

Country Status (28)

Country Link
EP (1) EP0636146B1 (enExample)
JP (1) JPH08500331A (enExample)
KR (1) KR950700935A (enExample)
CN (1) CN1039126C (enExample)
AT (1) ATE156135T1 (enExample)
AU (1) AU671118B2 (enExample)
BG (1) BG99110A (enExample)
BR (1) BR9306248A (enExample)
CA (1) CA2118253A1 (enExample)
CZ (1) CZ254294A3 (enExample)
DE (1) DE69312698T2 (enExample)
DK (1) DK0636146T3 (enExample)
ES (1) ES2105265T3 (enExample)
FI (1) FI944838A7 (enExample)
GR (1) GR3024348T3 (enExample)
HR (1) HRP930814A2 (enExample)
HU (1) HUT70189A (enExample)
IL (1) IL105381A (enExample)
IT (1) IT1262902B (enExample)
MX (1) MX9302161A (enExample)
NO (1) NO943861L (enExample)
NZ (1) NZ251969A (enExample)
RO (1) RO112872B1 (enExample)
RU (1) RU94045890A (enExample)
SK (1) SK124294A3 (enExample)
TW (1) TW234718B (enExample)
WO (1) WO1993021227A1 (enExample)
ZA (1) ZA932644B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1283171B1 (it) * 1996-03-01 1998-04-16 Interdipartimentale Di Ricerca Composti solubili antagonisti delle tachichinine loro preparazione e loro uso in composizioni farmaceutiche
IT1291776B1 (it) 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1307809B1 (it) 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
DE3915361A1 (de) * 1989-05-11 1990-11-15 Merck Patent Gmbh Cyclopeptide

Also Published As

Publication number Publication date
ITFI920089A0 (it) 1992-04-15
AU671118B2 (en) 1996-08-15
SK124294A3 (en) 1995-07-11
ES2105265T3 (es) 1997-10-16
WO1993021227A1 (en) 1993-10-28
CN1080916A (zh) 1994-01-19
TW234718B (enExample) 1994-11-21
FI944838L (fi) 1994-10-14
GR3024348T3 (en) 1997-11-28
RU94045890A (ru) 1996-09-10
RO112872B1 (ro) 1998-01-30
CZ254294A3 (en) 1995-07-12
IT1262902B (it) 1996-07-22
DE69312698T2 (de) 1997-12-04
AU4039593A (en) 1993-11-18
ZA932644B (en) 1993-10-22
NO943861D0 (no) 1994-10-13
CN1039126C (zh) 1998-07-15
HU9402977D0 (en) 1995-02-28
NZ251969A (en) 1997-12-19
IL105381A (en) 1998-02-22
HUT70189A (en) 1995-09-28
FI944838A0 (fi) 1994-10-14
DK0636146T3 (da) 1998-02-23
EP0636146B1 (en) 1997-07-30
DE69312698D1 (de) 1997-09-04
EP0636146A1 (en) 1995-02-01
ATE156135T1 (de) 1997-08-15
BG99110A (bg) 1995-09-29
FI944838A7 (fi) 1994-10-14
ITFI920089A1 (it) 1993-10-15
KR950700935A (ko) 1995-02-20
JPH08500331A (ja) 1996-01-16
HRP930814A2 (en) 1996-12-31
NO943861L (no) 1994-10-13
CA2118253A1 (en) 1993-10-28
BR9306248A (pt) 1998-06-23

Similar Documents

Publication Publication Date Title
ES2131106T3 (es) Compuestos de benzotiazepina hipolipidemicos.
ES2100187T3 (es) Derivados de carboestirilos y composiciones farmaceuticas que los contienen.
UY25804A1 (es) Derivados de 4-aroilpiperidina que son antagonistas de los receptores ccr-3
ES2127912T3 (es) Benzoderivados condensados.
ES8102131A1 (es) Procedimiento para preparar una composicion oral que com- prende un compuesto de 2-penem
ES2069401T3 (es) Composiciones detergentes.
ES2066781T3 (es) Nuevas n-(1-alquil-3-hidroxi-4-piperidinil)-benzamidas sustituidas.
ES2123560T3 (es) Composiciones farmaceuticas que comprenden derivados de hidroxamato para la eliminacion del hierro.
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
PT93160A (pt) Processo para a preparacao de benzenossulfonamidas e de composicoes farmaceuticas que as contem
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
MX9302161A (es) Compuestos triciclicos antagonistas de la taquiqu inina, proceso para su preparcion y composiciones farmaceuticas que los contienen.
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
MX9300840A (es) Compuestos farmaceuticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SU1049490A1 (ru) (3 @ ,9 @ ,9 @ )-6,6,9 @ -Триметилтранспергидронафто(2,1- @ )фуран,в качестве душистого компонента парфюмерной композиции
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BG99313A (en) 117-alkylketonesteroids as 5- -reductase inhibitors
ES2146722T3 (es) Nuevos analogos de la acronicina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2038694T3 (es) Procedimiento para la preparacion de los derivados de la 8-azaxantina alquilaminoalquil o heterociclilalquil sustituida en el anillo de triazol, asi como sales de la misma aceptables en la terapeutica.
DE59006419D1 (de) Benzylselenobenzamide von Anilinen und Benzylaminen.
ES2063305T3 (es) Derivados de bifenilo, procedimiento para la preparacion de los mismos e intermedios para los mismos.
ES2147825T3 (es) Derivados tetraciclicos de la 1,4-oxazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE59008844D1 (de) Benzylselenobenzamide von Aminopyridinen und Picolylaminen.
ES2031552T3 (es) 2-selenometil-1,4-dihidropiridinas, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.